SS Innovations International 將於 SRS 2026 展示 SSi Mantra 機械人系統並直播遠程腎臟手術

EX-99.1
2
ea029838101ex99-1.htm
PRESS RELEASE, DATED JULY 17, 2026

 

Exhibit 99.1

 

 

SS Innovations To Showcase the SSi Mantra Surgical
Robotic System at SRS 2026 

 

Company’s advanced surgical robotic system
will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier
industry event

 

FORT
LAUDERDALE, Fla. – July 17, 2026 – via IBN – SS Innovations International, Inc. (the “Company”
or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic
surgery affordable and accessible to a global population, today announced that the advanced SSi Mantra surgical robotic system (the “SSi
Mantra”) will be showcased at the 2026 Society of Robotic Surgery Annual Meeting (“SRS 2026”) in Hollywood, Florida,
on July 23 - 26, 2026. The SSi Mantra will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery
to be broadcast live at the event.

 

The livestreamed robotic telesurgery, a partial
nephrectomy, will be performed remotely by Dr. Amitabh Singh from SS Innovations’ headquarters in Gurugram, India, on a patient
at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi, India.

 

Additionally, the Company’s Chairman and
Chief Executive Officer, Dr. Sudhir Srivastava, will be speaking at SRS 2026. Dr. Srivastava is scheduled to participate in multiple breakout
sessions, including:

 

●Cardiac Telesurgery with the SSi Mantra (speaker)

 

●SSi Mantra Focus Sessions (speaker)

 

●Scaling Robotic Surgery for Global Access (speaker)

 

●Soft Tissue Robotics Update from Asia (panelist)

 

●Regulatory Frameworks Enabling Telesurgery (panelist)

 

●Industry Perspectives (panelist)

 

●Global and Military Sessions (panelist)

 

Dr. Srivastava commented: “We look forward
to showcasing our advanced SSi Mantra surgical robotic system next week in Florida at the Society of Robotic Surgery Annual Meeting, the
premier gathering of innovators shaping the future of robotic surgery. This influential forum provides us with a prime opportunity to
highlight the SSi Mantra’s cutting-edge surgical robotic technology, differentiated features, user friendliness, training capabilities,
and cost efficiency. During this year’s event, I will be participating as a speaker or panelist in several industry focus sessions
and will continue to share SS Innovations’ mission of democratizing global access to advanced surgical robotic care.”

 

To learn more about SRS 2026, please visit: https://srs2026.eventscribe.net/index.asp.

 

As of July 6, 2026, the cumulative number of multi-specialty
procedures completed with the SSi Mantra surgical robotic system totaled 12,375, including 653 cardiac procedures, 178 telesurgeries,
and 225 pediatric surgeries. Approximately 2,100 physicians have been trained on the SSi Mantra, which has been utilized to perform over
170 different types of procedures.

 

  

  

 

 

About SS Innovations 

 

SS Innovations International, Inc. (Nasdaq: SSII)
develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a
larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical
robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic
procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence
of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com
or LinkedIn for more information and updates.

 

About the SSi Mantra

 

The SSi Mantra surgical robotic system is a user-friendly,
modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command
center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic
patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon
console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that provides equivalent control
functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40
different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments
for the pediatric population and ENT surgeries. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon
to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 170 different types of surgical
procedures.

 

Forward Looking Statements

 

This press release may contain statements that
are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.
The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,”
“intend,” “may,” “plan,” “project,” “should,” “could,” “seek,”
“designed,” “potential,” “forecast,” “target,” “objective,” “goal,”
or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future
events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that
may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels
of activity, performance or achievements expressed or implied by these forward-looking statements.

 

Investor Contact:

 

The Equity Group 

Kalle Ahl, CFA 

T: (303) 953-9878 

[email protected]

 

Devin Sullivan, Managing Director

T: (212) 836-9608

[email protected]

 

Media Contact:

 

RooneyPartners LLC

Kate Barrette

T: (212) 223-0561

[email protected]

 

Corporate Communications:

 

IBN.Ai
Austin, Texas
www.IBN.ai
512.354.7000 Office

[email protected]